|
|
眼结膜MALT淋巴瘤1例并文献复习
|
Abstract:
目的：探讨眼结膜MALT淋巴瘤的放疗剂量及放疗后并发症的管理。方法：回顾性分析该院收治的1例眼结膜MALT淋巴瘤患者的临床资料，并结合国内外文献进行复习探讨。结果：患者以左眼结膜黄豆粒大小的新生肿物为主要临床表现，于外院行手术切除，术后病检示黏膜相关淋巴组织结外边缘区淋巴瘤。后患者行左眼调强放疗，剂量：95% PTV，30 Gy/2 Gy/15 F，放疗后随访1个月未见肿瘤复发、转移，患者诉眼干，余无特殊不适。结论：眼结膜MALT淋巴瘤临床较罕见，放射治疗疗效确切、并发症可控。
Objective: To investigate the dose of radiotherapy and the management of post-radiotherapy com-plications in conjunctival MALT lymphoma. Methods: The clinical data of a patient with conjunctival MALT lymphoma admitted to the hospital were retrospectively analyzed, and reviewed and dis-cussed with domestic and international literature. Results: The patient presented with a neoplastic mass the size of a soybean grain in the left conjunctiva as the main clinical manifestation and un-derwent surgical resection at an outside hospital. Postoperative pathological examination showed lymphoma in the extra-nodal marginal zone of mucosa-associated lymphoid tissue. The patient was treated with intensity-modulated radiotherapy in the left eye at a dose of 95% PTV, 30 Gy/2 Gy/15 F, and no tumor recurrence or metastasis was observed in the 1-month follow-up after radiotherapy. Conclusion: Conjunctival MALT lymphoma is rare clinically, and the efficacy of radiation therapy is precise and the complications are manageable.
| [1] | Sassone, M., Ponzoni, M. and Ferreri, A.J. (2017) Ocular Adnexal Marginal Zone Lymphoma: Clinical Presentation, Pathogenesis, Diagnosis, Prognosis, and Treatment. Best Practice and Research in Clinical Haematology, 30, 118-130.
https://doi.org/10.1016/j.beha.2016.11.002 |
| [2] | Tanenbaum, R.E., Galor, A., Dubovy, S.R., et al. (2019) Classifi-cation, Diagnosis, and Management of Conjunctival Lymphoma. Eye and Vision (London), 6, 22. https://doi.org/10.1186/s40662-019-0146-1 |
| [3] | Ferreri, A.J., Guidoboni, M., Ponzoni, M., et al. (2004) Evidence for an Association between Chlamydia psittaci and Ocular Adnexal Lymphomas. Journal of the National Cancer Insti-tute, 96, 586-594.
https://doi.org/10.1093/jnci/djh102 |
| [4] | Chanudet, E., Zhou, Y., Bacon, C.M., et al. (2006) Chlamydia psittaci Is Variably Associated with Ocular Adnexal MALT Lymphoma in Different Geographical Regions. The Journal of Pa-thology, 209, 344-351.
https://doi.org/10.1002/path.1984 |
| [5] | Collina, F., De Chiara, A., De Renzo, A., et al. (2012) Chlamydia psittaci in Ocular Adnexa MALT Lymphoma: A Possible Role in Lymphomagenesis and a Different Geographical Distribution. Infectious Agents and Cancer, 7, 8.
https://doi.org/10.1186/1750-9378-7-8 |
| [6] | Asao, K., Hashida, N. ando, S., et al. (2019) Conjunctival Dysbiosis in Mucosa-Associated Lymphoid Tissue Lymphoma. Scientific Reports, 9, Article No. 8424. https://doi.org/10.1038/s41598-019-44861-5 |
| [7] | Chung, H.U. and Son, J.H. (2022) Ocular Adnexal Muco-sa-Associated Lymphoid Tissue Lymphoma: A Narrative Review. Journal of Yeungnam Medical Science, 39, 3-11. https://doi.org/10.12701/yujm.2021.01263 |
| [8] | 朱豫. 原发性眼附属器MALT淋巴瘤的临床类型与个体化治疗[J]. 眼科学报, 2021, 36(9): 688-696. |
| [9] | Sarria, G.R., Cabrera, C.M., Sarria, G.J., et al. (2020) Single-Fraction Low-Energy Electronic Brachytherapy for Conjunctival Lymphoma. Journal of Contemporary Brachytherapy, 12, 267-272. https://doi.org/10.5114/jcb.2020.96869 |
| [10] | Shirota, N., Nakayama, H., Shiraishi, S., et al. (2017) Target Volume Dose and Clinical Outcome in Radiotherapy for Primary Marginal Zone Lymphoma of the Ocular Adnexa. Mo-lecular and Clinical Oncology, 6, 833-838.
https://doi.org/10.3892/mco.2017.1241 |
| [11] | Lee, G.I., Oh, D., Kim, W.S., et al. (2018) Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lymphoma. Cancer Research and Treatment, 50, 575-581. https://doi.org/10.4143/crt.2017.182 |
| [12] | Lee, M.J., Lee, M.Y., Choe, J.Y., et al. (2021) Ultra-Low-Dose Radia-tion Treatment for Early-Stage Ocular Adnexal MALT Lymphoma. European Journal of Ophthalmology. https://doi.org/10.1177/11206721211035622 |
| [13] | Scholz, S.L., Eckstein, A., Dekowski, D., et al. (2019) Current Therapies in Superficial Malignant Tumors. Laryngorhinootologie, 98, 685-694. https://doi.org/10.1055/a-0960-6490 |
| [14] | Park, H.H., Lee, S.W., Sung, S.Y., et al. (2017) Treatment Outcome and Risk Analysis for Cataract after Radiotherapy of Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. Radiation Oncology, 35, 249-256. https://doi.org/10.3857/roj.2017.00374 |
| [15] | Niwa, M., Ishikura, S., Tatekawa, K., et al. (2020) Radiotherapy Alone for Stage IE Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphomas: Long-Term Results. Radiation Oncology, 15, 25.
https://doi.org/10.1186/s13014-020-1477-8 |
| [16] | Cho, W.K., Lee, S.E., Paik, J.S., et al. (2013) Risk Potentiality of Frontline Radiotherapy Associated Cataract in Primary Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lympho-ma. Korean Journal of Ophthalmology, 27, 243-248. https://doi.org/10.3341/kjo.2013.27.4.243 |
| [17] | Kim, S.E., Yang, H.J. and Yang, S.W. (2020) Effects of Radiation Therapy on the Meibomian Glands and Dry Eye in Patients with Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma. BMC Ophthalmology, 20, Article No. 24. https://doi.org/10.1186/s12886-019-1301-0 |
| [18] | Goyal, S., Cohler, A., Camporeale, J., et al. (2008) Intensi-ty-Modulated Radiation Therapy for Orbital Lymphoma. Radiation Medicine, 26, 573-581. https://doi.org/10.1007/s11604-008-0276-1 |
